Literature DB >> 16781736

The crystal structure of the carboxy-terminal domain of human translation initiation factor eIF5.

Christoph Bieniossek1, Patrick Schütz, Mario Bumann, Andreas Limacher, Isabel Uson, Ulrich Baumann.   

Abstract

The carboxy-terminal domain (CTD) of eukaryotic initiation factor 5 (eIF5) plays a central role in the formation of the multifactor complex (MFC), an important intermediate for the 43 S pre-initiation complex assembly. The IF5-CTD interacts directly with the translation initiation factors eIF1, eIF2-beta, and eIF3c, thus forming together with eIF2 bound Met-tRNA(i)(Met) the MFC. In this work we present the high resolution crystal structure of eIF5-CTD. This domain of the protein is exclusively composed out of alpha-helices and is homologous to the carboxy-terminal domain of eIF2B-epsilon (eIF2Bepsilon-CTD). The most striking difference in the two structures is an additional carboxy-terminal helix in eIF5. The binding sites of eIF2-beta, eIF3 and eIF1 were mapped onto the structure. eIF2-beta and eIF3 bind to non-overlapping patches of negative and positive electrostatic potential, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781736     DOI: 10.1016/j.jmb.2006.05.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

Review 1.  Molecular view of 43 S complex formation and start site selection in eukaryotic translation initiation.

Authors:  Jon R Lorsch; Thomas E Dever
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

2.  Crystallographic ab initio protein structure solution below atomic resolution.

Authors:  Dayté D Rodríguez; Christian Grosse; Sebastian Himmel; César González; Iñaki M de Ilarduya; Stefan Becker; George M Sheldrick; Isabel Usón
Journal:  Nat Methods       Date:  2009-08-16       Impact factor: 28.547

3.  Crystallization and preliminary crystallographic studies of the W2 domain of Drosophila melanogaster eukaryotic translation initiation factor 5C domain-containing protein.

Authors:  Hui Zhao; Hong Wang; Huihui Liu; Maikun Teng; Xu Li
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-10-30

4.  Crystal structure of the C-terminal domain of the ɛ subunit of human translation initiation factor eIF2B.

Authors:  Jia Wei; Minze Jia; Cheng Zhang; Mingzhu Wang; Feng Gao; Hang Xu; Weimin Gong
Journal:  Protein Cell       Date:  2010-07-07       Impact factor: 14.870

5.  The Jigsaw Puzzle of mRNA Translation Initiation in Eukaryotes: A Decade of Structures Unraveling the Mechanics of the Process.

Authors:  Yaser Hashem; Joachim Frank
Journal:  Annu Rev Biophys       Date:  2018-03-01       Impact factor: 12.981

6.  eIF5 is a dual function GAP and GDI for eukaryotic translational control.

Authors:  Martin D Jennings; Graham D Pavitt
Journal:  Small GTPases       Date:  2010-09

7.  The interaction between eukaryotic initiation factor 1A and eIF5 retains eIF1 within scanning preinitiation complexes.

Authors:  Rafael E Luna; Haribabu Arthanari; Hiroyuki Hiraishi; Barak Akabayov; Leiming Tang; Christian Cox; Michelle A Markus; Lunet E Luna; Yuka Ikeda; Ryosuke Watanabe; Edward Bedoya; Cathy Yu; Shums Alikhan; Gerhard Wagner; Katsura Asano
Journal:  Biochemistry       Date:  2013-12-19       Impact factor: 3.162

8.  Critical contacts between the eukaryotic initiation factor 2B (eIF2B) catalytic domain and both eIF2beta and -2gamma mediate guanine nucleotide exchange.

Authors:  Sarah S Mohammad-Qureshi; Raphaël Haddad; Elizabeth J Hemingway; Jonathan P Richardson; Graham D Pavitt
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

Review 9.  Mechanism and Regulation of Protein Synthesis in Saccharomyces cerevisiae.

Authors:  Thomas E Dever; Terri Goss Kinzy; Graham D Pavitt
Journal:  Genetics       Date:  2016-05       Impact factor: 4.562

Review 10.  A new function and complexity for protein translation initiation factor eIF2B.

Authors:  Martin D Jennings; Graham D Pavitt
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.